Polaris Quantum Biotech (2024)
About this raise
Polaris Quantum Biotech, with a valuation of $5 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company uses the latest innovations in cloud and quantum computing, artificial intelligence, and machine learning to develop new drugs in a fraction of the time and cost of conventional methods. The platform and technology of Polaris Quantum Biotech scan billions of molecules from a large chemical space to find the molecules most suitable for drug development. Dr. Shahar Keinan and Bill Shipman founded Polaris Quantum Biotech in 2020. The current crowdfunding campaign has a minimum target of $11,200 and a maximum target of $530,000. The campaign proceeds will be used for growth and expansion.
Investment Overview
Invested : $490,376
Deal Terms
- Platform
- OurCrowd
- Start Date
- 11/26/2023
- Close Date
- 02/26/2024
$11,200
$530,000
$11,200
Convertible Note
Early Stage
RegD 506(c)
$5,000,000
0%
Company & Team
Company
- Year Founded
- 2020
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Location
- Durham, North Carolina
- Company Website
-
Visit Website
Team
Financials
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 02/26/2024 | OurCrowd | $5,000,000 | $490,376 | Convertible Note | Funded | RegD 506(c) |
| 09/19/2022 | OurCrowd | $40,000,000 | $355,503 | Convertible Note | Funded | RegD 506(c) |
| 07/23/2021 | OurCrowd | $11,500,000 | $1,302,372 | Equity - Common | Funded | RegD 506(c) |